The Comparison of CA۱۲۵ Levels in the Normal Pregnancy and Threatened Abortion

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 145

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JOGCR-7-3_014

تاریخ نمایه سازی: 6 بهمن 1400

چکیده مقاله:

Background & Objective: In pregnancy, the serum level of cancer antigen-۱۲۵ (CA-۱۲۵) increases in the first trimester and abortion. However, different studies reported conflicting results about the use of serum CA-۱۲۵ to determine the prognosis of threatened abortion. In the present study, we try to determine if the measurement of CA-۱۲۵ level could be used as a predictor of outcome in women with threatened abortion. Materials & Methods: This prospective case-control study was performed on ۵۸ patients with threatened abortion and ۵۸ healthy pregnant women with a gestational age of fewer than ۲۰ weeks (as the control group). In both groups, serum CA-۱۲۵ level was measured. The patients were followed to determine who completed the pregnancy period and who eventually miscarried. Finally, the levels of CA-۱۲۵ in these groups were compared. Results: The mean age of patients was ۲۸.۴۷ and ۲۷.۸۴ in the case and control groups, respectively; there was no significant statistical difference between the two groups (۹۵% CI: -۱.۹۴ to ۳.۱۸, P=۰.۶۳۲). Also, there was no significant difference between them for BMI (۹۵% CI: -۱.۰۹ to ۱.۳۸, P=۰.۸۱۳), gestational age (۹۵% CI: -۱.۳۱ to ۱.۰۴, P=۰.۸۱۶), and parity (P=۰.۵۱). The mean serum level of CA-۱۲۵ in the control group was ۲۲.۵۱ ± ۶.۸۲ IU/mL, and in the threatened abortion group was ۲۷.۷۰ ± ۷.۵۰ IU/mL. This difference was statistically significant (P<۰.۰۰۱). Of the patients, ۵۱.۷۲% with threatened abortion continued their pregnancy, and ۴۸.۲۸% eventually miscarried. The mean serum levels of CA-۱۲۵ were ۲۵.۳۰±۶.۶۳ IU/mL and ۳۰.۲۸±۷.۶۳ IU/ml in patients who continued the pregnancy and miscarried, respectively (P=۰.۰۱). Conclusion: A single measurement of the maternal CA-۱۲۵ may be used as an available, inexpensive prognostic test to determine the outcome of threatened abortion. However, a small number of patients is the main limitation of the present study. More studies with a larger sample size are required to accept the role of maternal CA-۱۲۵ in predicting the outcome of threatened miscarriage.

کلیدواژه ها:

نویسندگان

Esmat Barooti

Department of Obstetrics Gynecology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Farzaneh Rashidi Fakari

Department of Midwifery, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran

Soodabeh Darvish

Department of Obstetrics Gynecology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Narges Tavakoly

Department of Obstetrics Gynecology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Sotiriadis A, Papatheodorou S, Makrydimas GJB. Threatened miscarriage: evaluation and ...
  • Makrydimas G, Sebire N, Lolis D, Vlassis N, Nicolaides KJUiO, ...
  • Johns J, Hyett J, Jauniaux EJO, Gynecology. Obstetric outcome after ...
  • Al‐Sebai MAH, Kingsland CR, Diver M, Hipkin L, McFadyen IRJBAIJoO, ...
  • Florio P, Luisi S, D'Antona D, Severi FM, Rago G, ...
  • La Marca A, Morgante G, De Leo VJO, Gynecology. Human ...
  • Fiegler P, Katz M, Kaminski K, Rudol GJTJorm. Clinical value ...
  • Schmidt T, Rein DT, Foth D, Eibach H-W, Kurbacher CM, ...
  • Ghasemian Dizajmehr S, Sheikhhasani S, Mousavi A, Rashidi Fakari F, ...
  • Berek JS. Berek & Novak’s Gynecology Essentials: Lippincott Williams & ...
  • Check JH, Nowroozi K, Winkel CA, Johnson T, Seefried LJO, ...
  • Kobayashi F, Sagawa N, Nakamura K, Nonogaki M, Ban C, ...
  • Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast Jr ...
  • Ayaty S, Vahid Roudsari F, Tavassoly FJIJoRB. CA-۱۲۵ in normal ...
  • Yamane Y, Takahashi K, Kitao MJNSFGz. Prognostic potential of serum ...
  • Noci I, Biagiotti R, Periti E, Baronci D, Torricelli F, ...
  • نمایش کامل مراجع